Greg is a Senior Investment Manager for DSM Venturing with responsibility for health and wellness, nutrition, Ag Tech and Food Tech investments in North America. He joined DSM in 2011.  Prior to joining DSM Greg was CEO of several start-up and public companies including KIP Biotech, Avrio Biopharmaceuticals, and Girindus America Inc. He has held a variety of senior executive positions in operations, program management, engineering and business development at Altergy Fuel Cell Systems, Aerojet Pharmaceutical Fine Chemicals and Aerojet Rocket Propulsion Company.  Greg is a Board member for several DSM portfolio companies including Ganeden Biotech, ZeaVision, Natreon, Blue Prairie Brands and Harland Medical Systems.  He holds a Bachelor of Science degree in Chemical Engineering from Cornell University.